Physician profile
Amanda Parent
NPI 1669613774
$1,700.84
in general payments reported to CMS, 2019-2025
18 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2022: $92.73 · 2023: $386 · 2024: $417 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $467.80 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Otsuka America Pharmaceutical, INC. | $192.56 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $168.27 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Pfizer INC. | $129.42 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.20 | 2021-2022 | |
| Novo Nordisk INC | $111.55 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $111.15 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $101.31 | 2022-2025 | |
| Amarin Pharma, INC. | $58.23 | 2021 | |
| Genentech USA, INC. | $55.66 | 2021 | |
| Exact Sciences Corporation | $53.98 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $30.02 | 2021-2023 | Veozah |
| Idorsia Pharmaceuticals US INC | $20.46 | 2022 | |
| Dynavax Technologies Corporation | $19.05 | 2025 | Heplisav-B |
| Takeda Pharmaceuticals U.S.A., INC. | $17.01 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $15.26 | 2021 | |
| Althera Pharmaceuticals LLC | $14.18 | 2021 | |
| Abbott Laboratories | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Parent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.